Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05114369
Other study ID # 00
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2009
Est. completion date October 1, 2021

Study information

Verified date November 2021
Source Sanjay Gandhi Postgraduate Institute of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Various factors determine the long term survival in this non-uniform cohort of incidental gallbladder cancer. Timing of re-intervention is suggested to play an important role in the outcome. Few centers are proponents of early surgery in order to prevent dissemination, while others have suggested an intentional delay of 3 months to filter out cases with aggressive pathology. In the present study, investigators intend to evaluate the factors affecting survival in incidental Gallbladder Cancer (IGBC) with special reference to timing of re-intervention.


Description:

Surgical Gastroenterology department at our institute is a tertiary referral center for hepatobiliary malignancies; covering a large part of North and North-east India. The details and progress reports of patients of Gallbladder Cancer (GBC) being referred to and treated at the institute is maintained in a prospective manner on hospital data base. This includes demographic data, presenting complains, details of relevant investigations done outside and in the hospital, previous surgery, pre-hospital course, operative findings, post operative course and final histopathology. Being a retrospective analysis of data not affecting clinical outcomes, ethical approval was not taken. During the study period (Jan 2009 to Dec 2018), 1049 participants with diagnosis of GBC (including 91 IGBC participants) were admitted; 239/958 participants with diagnosis of GBC and 48/91 with diagnosis of GBC could undergo resection with curative intent. Information regarding adjuvant therapy, recurrence, and survival were retrieved through data maintained on follow up out-patient cards till December 2019. Few participants who stopped visiting the hospital were contacted telephonically or through letters. All available histopathology blocks and slides following the index cholecystectomy were re-reviewed by the pathologists in the institute. Tumor type, differentiation and primary T stage were documented for majority of cases. Interval between index cholecystectomy and date of re-operation was calculated for all the participants and divided into 3 groups: Early (<4weeks), Intermediate (4-12 weeks) and Late (>12 weeks). Primary objective was to assess the effect of tumor characteristics and the time gap (between index surgery and re-resection) on overall survival following curative (R0/R1) resection.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date October 1, 2021
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: All incidental carcinoma gallbladder patients who could undergo curative resection during the study period (Jan 2009 to Dec 2018) Exclusion Criteria: Metastasis on preoperative investigation or on staging laparoscopy

Study Design


Intervention

Procedure:
Curative surgery


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sanjay Gandhi Postgraduate Institute of Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Survival based on timing of completion radical cholecystectomy Overall and disease free survival 01.01.2009 to 31.12.2018
Secondary Determinants of factors associated with survival in incidental gallbladder carcinoma Factors related to primary surgery (residual disease, primary T stage), type of resection (Wedge resection, Segment 4B-5 excision or Common bile duct excision), tumor characteristics (differentiation and lymohovascular invasion) and final stage (AJCC 8th edition) 01.01.2009 to 31.12.2018
See also
  Status Clinical Trial Phase
Completed NCT01952184 - Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage. N/A
Completed NCT00993343 - Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation Phase 3
Recruiting NCT04808466 - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Phase 2
Not yet recruiting NCT04845490 - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Phase 2
Recruiting NCT03291275 - Survival Outcomes of Uterine Malignancies in Chinese Population N/A
Recruiting NCT05720858 - Telerehabilitation in Survival Breast Cancer Patients N/A
Completed NCT03351920 - Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
Not yet recruiting NCT06147180 - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Recruiting NCT04472403 - Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
Recruiting NCT03739944 - Different Surgical Approaches in Patients of Early-stage Cervical Cancer Phase 3
Not yet recruiting NCT02960061 - Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer Phase 3
Recruiting NCT03738969 - Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Completed NCT03134807 - The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
Completed NCT03084809 - Chemotherapy Combined With CIK Treating Colon Cancer Phase 4
Completed NCT03642041 - Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
Recruiting NCT04351308 - Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma Phase 2
Recruiting NCT03920033 - Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy N/A
Recruiting NCT05540119 - Swedish Oesophago-Gastric Study
Completed NCT04519450 - Ultrasound of Accessory Respiratory Muscles
Active, not recruiting NCT01835821 - Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns N/A